2530 Meridian Parkway, Suite 300
Biomarck is a biopharmaceutical company with a patented technology platform. We utilize anti-MARCKS peptides in order to develop and license products targeted at difficult to treat diseases with unmet needs. We are located in Research Triangle Park, N.C..
It has a worldwide patented drug platform of over 100 peptides that inhibit the phosphorylation of the MARCKS protein, a well published primary mediator of an inflammatory cytokine release involved in respiratory disease and cancer progression.
CEO: Brian Dickson, MD
CFO: Mike Enright
CSO: Indu Parikh, PhD
Please click here for clinical trial information.